Scholar Rock Holding Corporation (NASDAQ:SRRK) Receives Consensus Rating of “Buy” from Analysts

Posted by Geri Gentry on Sep 19th, 2026

Scholar Rock Holding Corporation (NASDAQ:SRRK – Get Free Report) has been given an average rating of “Buy” by the eighteen ratings firms that are presently covering the company, MarketBeat reports. Two research analysts have rated the stock with a sell rating, twelve have issued a buy rating and four have given a strong buy rating to the company. The average 12 month price objective among brokers that have updated their coverage on the stock in the last year is $66.00.

SRRK has been the subject of a number of recent research reports. Barclays cut Scholar Rock from an “overweight” rating to a “cautious” rating in a report on Tuesday. Citigroup lifted their price objective on Scholar Rock from $60.00 to $74.00 and gave the company a “buy” rating in a report on Monday, September 14th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Scholar Rock in a report on Friday, July 17th. Piper Sandler lifted their price target on shares of Scholar Rock from $60.00 to $75.00 and gave the company an “overweight” rating in a report on Tuesday. Finally, JPMorgan Chase & Co. boosted their price target on shares of Scholar Rock from $56.00 to $63.00 and gave the company an “overweight” rating in a research report on Thursday, August 13th.

Read Our Latest Stock Analysis on SRRK

Insider Buying and Selling at Scholar Rock

In related news, Director Michael Gilman sold 2,544 shares of the firm’s stock in a transaction on Wednesday, July 1st. The stock was sold at an average price of $53.87, for a total transaction of $137,045.28. Following the completion of the sale, the director directly owned 59,511 shares of the company’s stock, valued at $3,205,857.57. This trade represents a 4.10% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Katie Peng sold 5,446 shares of the business’s stock in a transaction on Wednesday, July 1st. The stock was sold at an average price of $53.88, for a total value of $293,430.48. Following the completion of the transaction, the director directly owned 34,301 shares in the company, valued at approximately $1,848,137.88. This represents a 13.70% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold 17,149 shares of company stock worth $923,108 over the last 90 days. Company insiders own 10.30% of the company’s stock.

Hedge Funds Weigh In On Scholar Rock

Large investors have recently modified their holdings of the stock. GAMMA Investing LLC raised its position in Scholar Rock by 20.8% in the 2nd quarter. GAMMA Investing LLC now owns 1,406 shares of the company’s stock worth $77,000 after purchasing an additional 242 shares during the last quarter. Values First Advisors Inc. raised its position in shares of Scholar Rock by 1.5% during the first quarter. Values First Advisors Inc. now owns 18,850 shares of the company’s stock worth $927,000 after acquiring an additional 286 shares during the last quarter. IFP Advisors Inc lifted its stake in shares of Scholar Rock by 294.1% during the fourth quarter. IFP Advisors Inc now owns 603 shares of the company’s stock valued at $27,000 after acquiring an additional 450 shares during the period. EverSource Wealth Advisors LLC boosted its holdings in Scholar Rock by 151.3% in the fourth quarter. EverSource Wealth Advisors LLC now owns 872 shares of the company’s stock valued at $38,000 after acquiring an additional 525 shares during the last quarter. Finally, Syon Capital LLC increased its position in Scholar Rock by 6.4% in the second quarter. Syon Capital LLC now owns 9,782 shares of the company’s stock worth $538,000 after purchasing an additional 588 shares during the period. 91.08% of the stock is currently owned by institutional investors and hedge funds.

Scholar Rock Price Performance

NASDAQ:SRRK opened at $46.65 on Monday. The company has a debt-to-equity ratio of 0.77, a current ratio of 7.02 and a quick ratio of 7.02. The stock has a market cap of $5.68 billion, a P/E ratio of -13.52 and a beta of 0.67. The company has a fifty day moving average price of $52.84 and a 200 day moving average price of $49.63. Scholar Rock has a one year low of $27.07 and a one year high of $61.76.

Scholar Rock (NASDAQ:SRRK – Get Free Report) last issued its quarterly earnings results on Thursday, August 6th. The company reported ($0.84) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.84). During the same period in the prior year, the business earned ($0.98) EPS. Analysts anticipate that Scholar Rock will post -3.24 earnings per share for the current year.

Scholar Rock Company Profile

(Get Free Report)

Scholar Rock, Inc is a biopharmaceutical company focused on developing medicines that selectively target growth factors in their latent forms. The company’s approach is designed to modulate the activation of growth factors in specific tissues, with the goal of addressing diseases in which these biological pathways contribute to impaired function or abnormal tissue growth.

Scholar Rock’s lead program is apitegromab, a monoclonal antibody designed to inhibit the activation of myostatin. The company has studied apitegromab as a potential treatment for spinal muscular atrophy, a genetic neuromuscular disorder that causes progressive muscle weakness and loss of motor function.